Spontaneously proliferating human B lymphocytes make autoantibodies.

Area of Science:

• Immunology
• Virology
• Autoimmunity

Background:

• Autoimmune diseases are characterized by the immune system attacking the body's own tissues.
• Epstein-Barr virus (EBV) is a common human herpesvirus that establishes lifelong latent infections.
• The role of latent viral infections in the development of autoimmune disorders remains an area of active research.

Purpose of the Study:

• To investigate the potential link between latent Epstein-Barr virus (EBV) infection and autoantibody production in patients with autoimmune diseases.
• To determine if EBV reactivation in vitro can induce the generation of autoantibodies.

Main Methods:

• Peripheral blood lymphocytes from autoimmune patients and healthy controls were cultured in vitro.
• Lymphocyte proliferation and cell line establishment were monitored.
• Presence of EBV nuclear antigen confirmed latent EBV infection.
• Culture supernatants were screened for autoantibodies against normal tissues.

Main Results:

• Lymphocyte outgrowth occurred only in cultures from patients with antibodies to EBV viral capsid antigen.
• Proliferating cells contained EBV nuclear antigen, indicating latent EBV infection.
• Approximately 30% of established cell lines produced autoantibodies, some reacting with smooth muscle or epithelial cells.

Conclusions:

• Latent EBV infection in patients with autoimmune diseases can be reactivated in vitro.
• Reactivated EBV infection is associated with the production of autoantibodies.
• In vivo reactivation of latent EBV may contribute to autoantibody production in various immunoregulatory disorders.